SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 5th, 2020 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This Securities Purchase Agreement (this “Agreement”) is dated as of May 5, 2020, between Pluristem Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
